Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $101.05 in the latest trading session, marking a +0.6% move from the prior day.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $102.26, marking a +1.57% move from the previous day.

The Zacks Analyst Blog Highlights Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway and Mitsubishi UFJ Financial Group

Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway, and Mitsubishi UFJ Financial Group are part of The Zacks top Analyst Blog.

Mark Vickery headshot

Top Research Reports for Microsoft, CVS Health & Lockheed Martin

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), CVS Health (CVS) and Lockheed Martin (LMT).

Buckle (BKE) Benefits From Solid Sales & Online Business

Buckle (BKE) reports higher sales and comparable store sales for August. BKE's men's and women's businesses continue to boost the top-line performance.

Company News for Sep 7, 2022

Companies In The News Are: BBBY, SGFY, CVS, LOW, ILMN.

CVS Health (CVS) to Buy Signify Health, Grow in Home Healthcare

According to CVS Health (CVS), Signify Health, as a leading healthcare platform, will play a critical role in advancing the company's healthcare services strategy.

Will Business Momentum Aid Home Depot (HD) Amid Cost Woes?

Home Depot (HD) looks well-poised on strength in Pro & DIY categories, robust housing market trends, digital momentum and ongoing investments despite cost woes.

Signet (SIG) Q2 Earnings Beat Estimates, Sales Fall Y/Y

Signet (SIG) delivers better-than-estimated second-quarter fiscal 2023 results. However, sales fall from the year-ago fiscal quarter's level due to weak same-store sales.

Why Is CVS Health (CVS) Down 1.9% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Big Lots' (BIG) Q2 Loss Narrower than Expected, Revenues Fall Y/Y

Big Lots (BIG) reports a narrower-than-expected loss per share for second-quarter fiscal 2022. Also, comparable sales fall 9.2% in the quarter and hurt overall sales.

Best Buy's (BBY) Q2 Earnings Beat, Comparable Sales Fall 12.1%

Best Buy (BBY) reports mixed second-quarter fiscal 2023 sales due to lower enterprise comparable sales.

J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli

J&J (JNJ) gets approval for Tecvayli (teclistamab) for the treatment of relapsed and refractory multiple myeloma. This marks the first approval for Tecvayli in any country.

Urban Outfitters (URBN) Q2 Earnings Miss, Sales Improve Y/Y

Urban Outfitters' (URBN) second-quarter fiscal 2023 earnings results reflect inflationary pressures from inbound freight expenses and transportation costs.

UnitedHealth (UNH) Eyes Signify Health Acquisition: Here's Why

UnitedHealth (UNH) is reportedly the highest bidder with more than $30 per share for Signify Health.

Foot Locker (FL) Stock Up 20% on Q2 Earnings & Sales Beat

Foot Locker (FL) posts better-than-expected earnings for second-quarter fiscal 2022. FL's FLX membership program and omni-channel capabilities appear encouraging.

CVS Health (CVS) Moves to Buy: Rationale Behind the Upgrade

CVS Health (CVS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SpartanNash's (SPTN) Earnings Beat in Q2, Sales Rise Y/Y

SpartanNash (SPTN) posts higher sales for the second quarter of 2022 on increased sales across all segments and solid comparable store sales.

This 1 Retail and Wholesale Stock Could Beat Earnings: Why It Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Lowe's (LOW) Q2 Earnings Beat Estimates, Sales Decline Y/Y

Lowe's (LOW) reports a solid earnings performance for second-quarter fiscal 2022. A healthy operating margin backed by gains from the Total Home strategy aids the bottom line.

Rajani Lohia headshot

Home Depot (HD) Q2 Earnings Beat, Stock Down on Soft Margins

Home Depot's (HD) Q2 results reflect continued strong demand for home-improvement projects. HD's results represented the highest ever sales and earnings in its history.

The Zacks Analyst Blog Highlights Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy

Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy are part of The Zacks top Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Eli Lilly, CVS Health & Target

Today's Research Daily features new research reports on 12 major stocks, including Eli Lilly and Company (LLY), CVS Health Corporation (CVS), and Target Corporation (TGT)

Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?

Here is how CVS Health (CVS) and Dollar Tree (DLTR) have performed compared to their sector so far this year.